Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Before-after study of oral L-arginine hydrochloride in amyotrophic lateral sclerosis
jRCTs061230001Completed
- Sponsor
- Japan Society for the Promotion of Science
- Start
- May 2023
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of arginine in amyotrophic lateral sclerosis (ALS), sponsored by Japan Society for the Promotion of Science. Primary endpoint: Safety. Started May 2023; status: completed.
02
Drugs
arginine
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on jRCTs061230001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061230001.